Civic Intelligence

Eicosanoid Research Foundation

990EZ • Fiscal year 2020 • EIN 27-0097769

Jan 01, 2020 to Dec 31, 2020 • Filed on Sep 27, 2021

Organization Profilewww.eicosanoidresearchfoundation.org
5101 Cass Avenue 431 Chemistry BldDetroit, MI 48202

(313) 577-2999

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

71st percentile

0.06x

Higher debt load relative to assets than 71% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Liabilities / Revenue

87th percentile

0.34x

Higher debt load relative to revenue than 87% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Net Margin

2nd percentile

-1034%

Higher net margin than 2% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

2020 filings • 501(c)3 • <$500k nonprofits • Source year 2020

Asset Growth

6th percentile

-64%

Faster asset growth than 6% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Revenue Growth

3rd percentile

-98%

Faster revenue growth than 3% of similar nonprofits.

2020 filings • 501(c)3 • <$500k nonprofits • Annualized from 2019 to 2020

Balance Sheet
Liabilities / Assets71st percentile

Assets

Down

$27,594

Down $50,027 (-64%) from 2019

Net Assets

Down

$25,895

Down $51,726 (-67%) from 2019

Liabilities

Up

$1,699

Up $1,699 from 2019

Revenue And Expenses
Liabilities / Revenue87th percentileNet Margin2nd percentile

Revenue

Down

$5,003

Down $256,028 (-98%) from 2019

Expenses

Down

$56,729

Down $169,550 (-75%) from 2019

Net Income

Down

-$51,726

Down $86,478 (-249%) from 2019

Historical Trend

Balance Sheet Trend

Asset Growth6th percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100K$50K$0-$50KAssets 2011: $65,562Liabilities 2011: $0Net Assets 2011: $65,5622011Assets 2012: $44,754Net Assets 2012: $44,7542012Assets 2013: $831Net Assets 2013: $8312013Assets 2014: $14,630Net Assets 2014: $14,6302014Assets 2015: $12,688Net Assets 2015: $12,6882015Assets 2016: $39,489Net Assets 2016: $39,4892016Assets 2017: $71,362Liabilities 2017: $0Net Assets 2017: $71,3622017Assets 2018: $45,889Liabilities 2018: $3,020Net Assets 2018: $42,8692018Assets 2019: $77,621Liabilities 2019: $0Net Assets 2019: $77,6212019Assets 2020: $27,594Liabilities 2020: $1,699Net Assets 2020: $25,8952020Assets 2021: $88,983Liabilities 2021: $4,745Net Assets 2021: $84,2382021Assets 2022: $17,889Liabilities 2022: $0Net Assets 2022: $17,8892022Assets 2023: $10,801Liabilities 2023: -$742Net Assets 2023: $11,5432023

Highlighted filing

2020

Assets$27,594
Liabilities$1,699
Net Assets$25,895
Open 2020 Filing

Operations Trend

Revenue Growth3rd percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$400K$300K$200K$100K$0-$100KExpenses 2011: $303,4022011Revenue 2012: $445Expenses 2012: $21,253Net Income 2012: -$20,8082012Revenue 2013: $176,062Expenses 2013: $219,985Net Income 2013: -$43,9232013Revenue 2014: $36,573Expenses 2014: $22,774Net Income 2014: $13,7992014Revenue 2015: $165,204Expenses 2015: $167,146Net Income 2015: -$1,9422015Revenue 2016: $46,961Expenses 2016: $14,415Net Income 2016: $32,5462016Revenue 2017: $255,293Expenses 2017: $227,286Net Income 2017: $28,0072017Revenue 2018: $28,463Expenses 2018: $56,956Net Income 2018: -$28,4932018Revenue 2019: $261,031Expenses 2019: $226,279Net Income 2019: $34,7522019Revenue 2020: $5,003Expenses 2020: $56,729Net Income 2020: -$51,7262020Revenue 2021: $78,803Expenses 2021: $20,460Net Income 2021: $58,3432021Revenue 2022: $265,748Expenses 2022: $332,097Net Income 2022: -$66,3492022Revenue 2023: $20,080Expenses 2023: $26,426Net Income 2023: -$6,3462023

Highlighted filing

2020

Revenue$5,003
Expenses$56,729
Net Income-$51,726
Open 2020 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Sep 27, 2021
Return Version
2020v4.0
Gross Receipts
$5,003
Mission and Program Overview

Mission

The primary exempt purpose of the eicosanoid research foundation is to provide a forum for the dissemination of the latest scientific information on bioactive lipids in health and disease as it relates to cancer, inflamation and inflamation induced diseases such as cardiovascular, diabetes, psoriasis and alzheimer's. This purpose is accomplished through the organization's bi-annual conference. The eicosanoid research foundation sponsors bi-annual conferences highlighting data at the cutting edge of medical science. During these conferences new drugs and medications are discussed, data on clinical trials is examined and scientists from all over the world interact to enhance their collaborative research efforts. The goal of this meeting series is to promote the exchange of information and ideas among international scientists of diverse backgrounds.the main purpose of the eicosanoid research foundation is to raise funds to sponsor the international conference on bioactive lipids in cancer

Program Services

DescriptionGrantsExpenses
BI-ANNUAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2019 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER.THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY IN THE INITIAL STAGES OF PLANNING THE 17TH BI-ANNUAL INTERNATIONAL CONFERENCE SCHEDULED TO BE HELD IN NEW ORLEANS, LOUISIANA USA FROM OCTOBER 30, 2022 TO NOVEMBER 2, 2022. THE CONFERENCE THAT WAS TO BE HELD IN DUBLIN,IRELAND IN THE FALL OF 2021 HAS BEEN CANCELED DUE TO THE COVID-19 PANDEMIC.$55,194-
ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM:THE WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS INCELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION.THE 7TH WSU LIPIDS SYMPOSIUM WAS SCHEDULED FOR MAY 13, 2020 IN THE STUDENT BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY. DUE TO THE COVID-19 PANDEMIC, THE EVENT WAS CANCELED. THE SYMPOSIUM IS EXPECTED TO RESUME AT A CURRENTLY UNDETERMINED DATE IN THE NEAR FUTURE.PREVIOUSLY, THE (6TH) WSU LIPIDS SYMPOSIUM WAS HELD IN THE STUDENT CENTER BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY ON MAY 7, 2019 AND WAS WELL ATTENDED.--
Compensation and Service Providers
Top Officer Pay76th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Kenneth V Honn PhDDirector-$0--
Edward A Dennis PhDDirector-$0--
Lawrence J Marnett PhDDirector-$0--
Charles Serhan PhDDirector-$0--
Gabor J Tigyi MD PhDDirector-$0--
Makoto Arita PhDDirector-$0--
Takehiko Yokomizo MD PhDDirector-$0--
Filing and Contact Details

Filer

Filer Name
Eicosanoid Research Foundation
EIN
27-0097769
Phone
3135772999
Address
5101 CASS AVENUE 431 CHEMISTRY BLD, DETROIT, MI 48202

Signing Officer

Name
Dr Kenneth V Honn
Title
Director
Signed
2021-09-27
Discuss with paid preparer
Yes

Preparer

Firm
Derderian Kann Seyferth & Salucci PC
Address
3001 West Big Beaver Suite 700, Troy, MI 48084
Preparer
Lawrence B Graves Jr CPA
Phone
2486493400
Supplemental Narrative

Additional Explanations

Other Expenses.1001

“Advertising and Promotion $49”

Other Expenses.1002

“Office Expenses $310”

Other Expenses.1003

“Information Technology $180”

Other Expenses.1005

“Travel $1202”

Other Expenses.1007

“Conferences, Conventions, and Meetings $193”

Other Expenses.1008

“Interest $157”

Other Expenses.1

“Bank Charges and Fees $354”

Other Expenses.3

“Annual Report Fees $40”

Other Expenses.4

“DUES $20”

Total Liabilities.1001

“Accounts Payable and Accrued Expenses - Beginning $0 Accounts Payable and Accrued Expenses - Ending $1699”

Raw XML Appendix204 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0KENNETH V HONN
IRS990EZ/BooksInCareOfDetail/PhoneNum03135772999
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt05101 CASS AVENUE 431 CHEMISTRY BLD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0DETROIT
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MI
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd048202
IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt077621
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt027594
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt05000
IRS990EZ/CostOfGoodsSoldAmt00
IRS990EZ/CostOrOtherBasisExpenseSaleAmt00
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-51726
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt054059
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt077621
IRS990EZ/Form990TotalAssetsGrp/EOYAmt027594
IRS990EZ/FundraisingGrossIncomeAmt00
IRS990EZ/GrossReceiptsAmt05003
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InvestmentIncomeAmt03
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesBOYAmt077621
IRS990EZ/NetAssetsOrFundBalancesEOYAmt025895
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt077621
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt025895
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt03.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt11.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt21.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt31.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt41.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt51.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt61.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt40
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt50
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt60
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Kenneth V Honn PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Edward A Dennis PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Lawrence J Marnett PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Charles Serhan PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm4Gabor J Tigyi MD PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm5Makoto Arita PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm6Takehiko Yokomizo MD PhD
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt4Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt5Director
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt6Director
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt02505
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BI-ANNUAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BI-ANNUAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS.THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER
IRS990EZ/PrintingPublicationsPostageAmt0165
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0BI-ANNUAL BIOACTIVE LIPIDS CONFERENCE: THE ORGANIZATION HELD AN INFORMATIVE AND SUCCESSFUL CONFERENCE IN THE FALL OF 2019 RELATING TO THE DISSEMINATION OF THE LATEST SCIENTIFIC AND MEDICAL INFORMATION ON BIO-ACTIVE LIPIDS IN HEALTH AND DISEASE, AS THEY RELATE TO CANCER.THE CONFERENCE SUCCESSFULLY PROMOTED THE EXCHANGE OF IDEAS AND THEORIES IN THIS AREA AMONG SCIENTISTS AND MEDICAL PROFESSIONALS AROUND THE WORLD, IN AN EFFORT TO FIND A CURE FOR CANCER. THE ORGANIZATION IS CURRENTLY IN THE INITIAL STAGES OF PLANNING THE 17TH BI-ANNUAL INTERNATIONAL CONFERENCE SCHEDULED TO BE HELD IN NEW ORLEANS, LOUISIANA USA FROM OCTOBER 30, 2022 TO NOVEMBER 2, 2022. THE CONFERENCE THAT WAS TO BE HELD IN DUBLIN,IRELAND IN THE FALL OF 2021 HAS BEEN CANCELED DUE TO THE COVID-19 PANDEMIC.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1ANNUAL WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM:THE WAYNE STATE UNIVERSITY LIPIDS SYMPOSIUM ADDRESSES THE VITAL ROLES OF LIPIDS INCELLULAR PROCESSES REQUIRED FOR NORMAL PHYSIOLOGICAL FUNCTION.THE 7TH WSU LIPIDS SYMPOSIUM WAS SCHEDULED FOR MAY 13, 2020 IN THE STUDENT BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY. DUE TO THE COVID-19 PANDEMIC, THE EVENT WAS CANCELED. THE SYMPOSIUM IS EXPECTED TO RESUME AT A CURRENTLY UNDETERMINED DATE IN THE NEAR FUTURE.PREVIOUSLY, THE (6TH) WSU LIPIDS SYMPOSIUM WAS HELD IN THE STUDENT CENTER BALLROOM ON THE MAIN CAMPUS OF WAYNE STATE UNIVERSITY ON MAY 7, 2019 AND WAS WELL ATTENDED.
IRS990EZ/ProgramSrvcAccomplishmentGrp/GrantsAndAllocationsAmt055194
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SpecialEventsDirectExpensesAmt00
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0MI
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt01699
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedOnOrganizationMgrAmt00
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TaxReimbursedByOrganizationAmt00
IRS990EZ/TotalExpensesAmt056729
IRS990EZ/TotalProgramServiceExpensesAmt055194
IRS990EZ/TotalRevenueAmt05003
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0www.eicosanoidresearchfoundation.org
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt05000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt095299
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt028450
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt0104540
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt046960
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0280249
IRS990ScheduleA/GovtFurnSrvcFcltsVl509Grp/TotalAmt00
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt03
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt017
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt013
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt08
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt01
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt042
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt0165715
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0150744
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt0316459
IRS990ScheduleA/GrossReceiptsNonUnrltBusGrp/TotalAmt00
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt03
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt017
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt013
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt08
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt01
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt042
IRS990ScheduleA/InvestmentIncomeCYPct00.00010
IRS990ScheduleA/InvestmentIncomePYPct00.00010
IRS990ScheduleA/NetIncomeFromOtherUBIGrp/TotalAmt00
IRS990ScheduleA/OtherIncome509Grp/TotalAmt00
IRS990ScheduleA/Post1975UBTIGrp/TotalAmt00
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99990
IRS990ScheduleA/PublicSupportPY509Pct00.99990
IRS990ScheduleA/PublicSupportTotal509Amt0596708
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/TaxRevLeviedOrgnztnlBnft509Grp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt05000
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0261014
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt028450
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0255284
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt046960
IRS990ScheduleA/Total509Grp/TotalAmt0596708
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt05003
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0261031
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt028463
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0255292
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt046961
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0596750
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Advertising and Promotion $49
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Office Expenses $310
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Information Technology $180
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3Travel $1202
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4Conferences, Conventions, and Meetings $193
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt5Interest $157
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt6Bank Charges and Fees $354
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt7Annual Report Fees $40
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt8DUES $20
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt9Accounts Payable and Accrued Expenses - Beginning $0 Accounts Payable and Accrued Expenses - Ending $1699
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Other Expenses.1001
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Other Expenses.1002
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Other Expenses.1003
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3Other Expenses.1005
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4Other Expenses.1007
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc5Other Expenses.1008
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc6Other Expenses.1
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc7Other Expenses.3
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc8Other Expenses.4
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc9Total Liabilities.1001
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/FederatedAssuranceLevelCd0FAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd02
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0DR KENNETH V HONN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0Director
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-09-27
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0EICOSANOID RESEARCH FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0EICO
ReturnHeader/Filer/EIN0270097769
ReturnHeader/Filer/PhoneNum03135772999
ReturnHeader/Filer/USAddress/AddressLine1Txt05101 CASS AVENUE 431 CHEMISTRY BLD
ReturnHeader/Filer/USAddress/CityNm0DETROIT
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MI
ReturnHeader/Filer/USAddress/ZIPCd048202
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0381944367
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Derderian Kann Seyferth & Salucci PC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt03001 West Big Beaver Suite 700
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Troy
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0MI
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd048084
ReturnHeader/PreparerPersonGrp/PhoneNum02486493400
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0LAWRENCE B GRAVES JR CPA
ReturnHeader/ReturnTs02021-10-04T10:56:22-07:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0DR KENNETH V
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0HONN
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2020 • Form 990EZDetailed filing. Detailed filing data is available for this year.

Open filing
Assets
$27,594
Liabilities
$1,699
Net assets
$25,895
Revenue
$5,003
Expenses
$56,729
Net income
-$51,726
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Detailed filing. Detailed filing data is available for this year.$0.11$0.01$0.12$0.20$0.26$0.06
2022Detailed filing. Detailed filing data is available for this year.$0.18$0.00$0.18$2.66$3.32$0.66
2021Detailed filing. Detailed filing data is available for this year.$0.89$0.05$0.84$0.79$0.20$0.58
2020Detailed filing. Detailed filing data is available for this year.$0.28$0.02$0.26$0.05$0.57$0.52
2019Detailed filing. Detailed filing data is available for this year.$0.78$0.00$0.78$2.61$2.26$0.35
2018Detailed filing. Detailed filing data is available for this year.$0.46$0.03$0.43$0.28$0.57$0.28
2017Detailed filing. Detailed filing data is available for this year.$0.71$0.00$0.71$2.55$2.27$0.28
2016Detailed filing. Detailed filing data is available for this year.$0.39$0.39$0.47$0.14$0.33
2015Detailed filing. Detailed filing data is available for this year.$0.13$0.13$1.65$1.67$0.02
2014Detailed filing. Detailed filing data is available for this year.$0.15$0.15$0.37$0.23$0.14
2013Detailed filing. Detailed filing data is available for this year.$0.01$0.01$1.76$2.20$0.44
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.45$0.45$0.00$0.21$0.21
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.66$0.00$0.66$3.03